Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 μg day−1 delivered as an extrafine aerosol in adults with moderate asthma
- 30 June 1998
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 92, 17-22
- https://doi.org/10.1016/s0954-6111(98)90213-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily doseRespiratory Medicine, 1998
- Pharmacokinetics and dose proportionality of beclomethasone from three strengths of a CFC-free beclomethasone dipropionate metered-dose inhalerBiopharmaceutics & Drug Disposition, 1997
- A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthmaAllergy, 1994
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- Use of inhaled corticosteroids in patients with mild asthma.Thorax, 1990
- Design of Bioavailability/Bioequivalence StudiesDrug Information Journal, 1990
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987